When you are diagnosed with a metastatic brain tumor, you want to get your treatment where research is finding answers—right now.
Researchers at the Johns Hopkins Metastatic Brain Tumor Center are actively pursuing new treatments through a range of clinical studies, all focused on improving outcomes in patients like you. Current clinical trials like these are exploring combinations of chemotherapy, radiation, and surgery to effect optimal results:
- Iniparib in Combination with Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis. Read more
- SRS (Stereotactic Radiosurgery) Plus Ipilimumab. Read more
- HKI-272 for HER2-Positive Breast Cancer and Brain Metastases. Read more
- A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases. Read more
Insights Defining the Field
Researchers at Johns Hopkins also are published in the most prestigious medical journals. Read the 10 New Research Papers from the metastatic brain tumor team at Johns Hopkins.
Put Yourself in the Best Hands
When you choose Johns Hopkins, you can feel confident knowing that you’re receiving quality, caring treatment in the same place where researchers are working day and night to manage the challenges of metastatic brain tumors.